Principal Findings
WeChat-based
HYPERTENSION
This randomized clinical trial demonstrated that the novel WeChat-based mHealth management for BP using digital transformation of baseline data and online health information was effective in the multimodal intervention group as compared to the usual care group. This system was conducive to better BP control rates (<140/90 mm Hg and <130/80 mm Hg), and lower SBP levels. Concurrently, it enhanced lifestyle modifications and contributed to constant improvement in the QoL of Chinese patients with new-onset hypertension.